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Total Antioxidant Capacity and C-Reactive Protein Levels
in Patients with Community-Acquired Pneumonia
Aims: The aim of this study was to evaluate the oxidative stress measured by serum total antioxidant capacity
(TAC) and malondialdehyde (MDA) in patients with community-acquired pneumonia (CAP), and to evaluate
their possible correlation with the serum C-reactive protein (CRP) and pneumonia severity index (PSI).
Materials and Methods: The PSI, chest X-ray (CXR) scores, and the serum TAC, MDA, and CRP levels were
determined in 67 CAP patients on admission and compared to 45 healthy controls.
Results: In the whole study population, the TAC level was inversely correlated with CRP levels and WBC
counts (r=-0.648, P=0.0001; r=-0.626, P=0.0001, respectively). Lower TAC and higher MDA levels were
found in CAP patients compared with those of controls (P = 0.0001, P = 0.029). Although the mean serum
MDA and TAC levels were similar between the groups of PSI class I-III (n=45) and PSI class IV-V (n=22), the
radiological scores (2.36±1.23 vs 3.19±1.17) and CRP levels (138.67 ± 63.86 vs 177.14 ± 56.43) were
significantly higher in the latter group (P = 0.010 and P=0.005, respectively).
Conclusions: Single measurement of serum MDA or TAC levels in CAP patients, in contrast to CRP level
measurement, does not seem to predict the severity of disease.
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Toplum Kökenli Pnömoni Hastalarında Total Antioksidan
Kapasite ve C-Reaktif Protein Düzeyleri
Amaç: Bu çalışmanın amacı toplum kökenli pnömoni (TKP) hastalarındaki sistemik oksidatif stres düzeyini
serum total antioksidan kapasite (TAK) ve malondialdehid (MDA) düzeylerini ölçerek değerlendirmek, serum
C-reaktif protein (CRP) ve pnömoni ağırlık indeksi (PSI) ile olası ilişkilerini incelemektir.
Yöntem ve Gereç: PSI, akciğer grafi skoru ve serum TAK, MDA, CRP düzeyleri 67 TKP hastasında hastaneye
başvuru gününde çalışıldı ve 45 sağlıklı kontrol grubu ile karşılaştırıldı.
Bulgular: Tüm çalışma grubunda, TAK düzeyi CRP düzeyi ve lökosit sayısı ile ters korelasyon gösterdi
(r=-0.648, P=0.0001; r=-0.626, P=0.0001, sırasıyla). TKP olgularında, kontrol grubuna göre daha düşük
TAK ve daha yüksek MDA düzeyleri bulundu (P=0.0001, P = 0.029). Ortalama TAK ve MDA düzeyleri düşük
PSI risk grubu (grup I-III, n=45) ve yüksek PSI risk (grup IV-V, n=22) gruplarında benzer olmasına karşılık,
ortalama radyolojik skorlar (2.36±1.23 ve 3.19±1.17) ve CRP düzeyleri (138.67 ± 63.86 ve 177.14 ±
56.43) sonraki grupta daha yüksek bulundu (P = 0.010 ve P = 0.005, sırasıyla).
Sonuç: Toplum kökenli pnömoni olgularında, CRP ölçümünün tersine, hastalığın ciddiyetini belirlemek için
serum TAK veya MDA düzeylerinin bir kez ölçülmesi yetersiz gibi gözükmektedir.
Anahtar Sözcükler: Toplum kökenli pnömoni, C-reaktif protein, malondialdehid, oksidatif stres, pnömoni
ağırlık indeksi, total antioksidan kapasite
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Introduction
The imbalance between oxidants and antioxidants is referred to as oxidative stress
and has been associated with various respiratory disorders. Increased oxidative stress
participates in the pathogenesis of both airways and parenchymal lung diseases. Asthma,
chronic obstructive pulmonary disease (COPD) and bronchiectasis have been associated
with inflammation and increased levels of oxidative stress (1-4). Oxidative stress
markers including hydrogen peroxide (H2O2), 8-isoprostane or malondialdehyde (MDA)
have been determined in various biological samples, as in blood, sputum,
bronchoalveolar lavage (BAL) fluid, and exhaled breath condensate (EBC) collected from
537
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patients with lung diseases (1,5-8). During bacterial
pneumonia, rapid and massive influx of activated
phagocytes into the distal airways is observed (9). These
phagocytic cells release excess reactive oxygen species
(ROS) when they encounter bacteria, as part of the host
defense against infection. ROS are also produced by
bacteria during aerobic respiration. Enhanced ROS
production may induce peroxidative lipid damage in which
MDA is one of the most important products of the socalled thiobarbituric acid reactive substances (TBARS).
This damage may further increase during the
phagocytosis if the ROS are not adequately scavenged by
blood antioxidants and antioxidant enzymes.
Community-acquired pneumonia (CAP) is the most
common infection-related cause of death (10,11).
Prognostic scores for CAP have been developed to assess
pneumonia severity to make a clinical judgement and to
guide decisions about treatment settings (12-14).
Severity-based approach for the management of
diagnosis and treatment of adult patients with CAP is
recommended by most of the guidelines, including the
American Thoracic Society (ATS), British Thoracic Society
(BTS), and Turkish Thoracic Society (TTS) pneumonia
guidelines (15-17). Several inflammatory biomarkers,
including C-reactive protein (CRP), can be used for
diagnosing or predicting the disease severity in patients
with pneumonia (18).
There are a few clinical studies in which oxidative
stress was evaluated in pneumonia patients (9,19-24).
However, the relationships between oxidative stress and
serum CRP or disease severity have not been extensively
studied. Therefore, the aim of this study was to
determine the level of oxidative stress assessed by serum
total antioxidant capacity (TAC) and MDA, and to evaluate
the relationship between oxidative stress and serum CRP
as well as disease severity in patients with CAP.

Materials and Methods
Study Subjects
The study was conducted at Suleyman Demirel
University Research and Practice Hospital, a tertiary-care
teaching hospital, between May 2005 and December
2006. Consecutive adult CAP patients were enrolled in
the study. Diagnosis of CAP was based on the presence of
a new infiltrate on the chest radiographs and clinical
findings. Clinical diagnosis of CAP was supported by at
538
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least two of the following signs and symptoms: cough,
pleuritic chest pain, dyspnea, rales and/or pulmonary
consolidation on physical examination, fever (axillary
temperature > 38°C), or leukocytosis (white blood cell
9
[WBC] count >10 × 10 /L), and no alternative diagnosis
during follow-up (19). Sputum gram stain, sputum
culture, blood and/or pleural fluid culture were
performed to achieve an etiological diagnosis. Exclusion
criteria from the study were: 1) immunosuppression or
immunosuppressive therapy (defined as daily doses of
≥20 mg prednisolone equivalent for >2 weeks); 2)
3
neutropenia (less than 1,000 neutrophils/mm ; 3) prior
antimicrobial treatment before the hospital admission; or
4) prior usage of medications with known antioxidative
properties during the last month prior to admission.
Diabetic patients with blood glucose levels >150 mg/dl
were also not included in the study, in order to avoid
falsely increased TAC values due to autoxidation of
glucose.
Evaluation of Disease Severity
Patients underwent a posteroanterior and lateral
chest X-ray (CXR) on the day of admission. Unilateral or
bilateral involvement, lobar consolidation and/or the
presence of pleural effusion were recorded. The CXRs
were evaluated by one of the authors (AB) and pneumonic
changes were graded on a scale from 0 to 10 points as
suggested by Majewska et al. (21). Briefly, the number of
pulmonary fields involved by inflammatory infiltrate
(from 0 to 6 points); the type of infiltration
[nonhomogeneous and mostly hazy (1 point) or dense
and coalesce (2 points)]; and the presence of pleural
effusion [unilateral (1 point) or bilateral (2 points)] were
evaluated.
Data about age, sex, smoking habits and comorbid
diseases (COPD, cardiac, liver, renal diseases, central
nervous system or digestive disorders and neoplasm)
were collected. Severity indicators of pneumonia such as
mental confusion, systolic and diastolic blood pressure,
respiratory rate, creatinine, blood urea nitrogen, sodium,
blood glucose, and arterial oxygen tension (PaO2) were
recorded. A total severity score was calculated for each
patient according to pneumonia severity index (PSI)
proposed by Fine et al. (12) within 24 hours of
admission. Diagnostic work-up was performed according
to the declaration of Helsinki ethical principles for medical
research involving human subjects, and written informed
consent was obtained from all study subjects.
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Measurements
Blood samples were obtained from all patients for
WBC counts, CRP level and other routine biochemical
tests on the day of admission. The WBC levels were
measured by COULTER® STKS™ Hematology Flow
Cytometer and CRP concentration was measured using
nephelometric method with a commercially available kit
(Dade Behring, Marburg, Germany). For arterial blood
gas analyses, blood was drawn from the radial artery
while the patients were breathing room air. Arterial
oxygen tension was analyzed with a blood gas analyzer
Ò
(Roche OMNI C, Roche Diagnostics, Germany). Blood
samples for TAC and MDA were obtained under fasting
condition 12 h before sample collection. These samples
were centrifuged at 1500 × g for 10 min and stored at 70°C until analyses. TAC was determined with an
automated measurement method described by Erel (24).
MDA was estimated by the measurement of TBARS.
TBARS were measured in plasma with the method
described by Draper and Hadley (25). Blood samples
were also collected from 45 nonsmoker healthy subjects
to establish the reference intervals of serum TAC and
MDA.
Statistical Analysis
Values are presented as mean ± SD. Statistical
analysis was performed with the SPSS 11.0 for Windows
programs. Correlation analyses were performed by using
Spearman rank correlation. Frequency comparison was
done by chi-square test. Two-group comparison of
normally distributed data was performed by Student's-t
test. For multigroup comparisons, one-way analysis of
variance (ANOVA) with least square difference for
posthoc comparison was applied. For data not normally
distributed, the Mann-Whitney U test was used if only
two groups were compared and the Kruskal-Wallis oneway ANOVA was used if more than two groups were
being compared. A P value of less than 0.05 was
considered to be significant for all tests.

Results
Sixty-seven adult CAP patients (84% male, age range:
19-82 years) and 45 nonsmoker healthy control subjects
(87% male, age range: 20-72 years) were included in the
study. The age and gender distribution were similar in
these two groups. Baseline clinical features of the study
population are presented in Table 1. In the whole study
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Table 1. Some clinical and laboratory variables in CAP patients in
comparison with control subjects.

Gender F/M
Mean age, years
Smokers
Nonsmokers
9
WBC, 10 × 10 /L
CRP, mg/L
MDA, nmol/L
TAC, mmol Trolox equivalent/L
PSI

Healthy controls
n = 45

CAP patients
n = 67

6/39
41 ± 22
0
45
7.8 ± 1.0
2.3 ± 0.9
2.875 ± 0.552
3.139 ± 0.329

11/56
40 ± 23
36
31
17.3 ± 8.9
151.0 ± 63.3
3.195 ± 0.861
1.903 ± 0.673
66.4 ± 45.4

CAP: community-acquired pneumonia; WBC: white blood cell count;
CRP: C-reactive protein; MDA: malondialdehyde; TAC: total antioxidant capacity; PSI: pneumonia severity index.

population, serum TAC concentration was inversely
correlated with CRP levels and WBC counts (r=-0.648,
P=0.0001; r=-0.626, P=0.0001, respectively);
however, no such correlation was observed for the serum
MDA concentrations. The mean TAC level was
significantly lower and the mean MDA level significantly
higher in CAP patients compared with levels in control
subjects (P=0.0001 and P=0.029, respectively), (Table
1).
In CAP patients, serum TAC levels were correlated
with smoking history (pack-years), fever, and erythrocyte
sedimentation rate (r=0.254, P=0.039; r=0.249,
P=0.042; r=0.252, P=0.05, respectively). Thirty-six
patients (54%) were current smokers and serum mean
TAC level was significantly higher in this group than in
nonsmokers (2.056 ± 0.686 vs 1.725 ± 0.621,
P=0.043, respectively).
At least one comorbid disease was detected in 34%
(n=23) of patients, as follows: diabetes mellitus: 11 (but
not hyperglycemic more than 150 mg/dl), COPD: 5,
congestive heart failure: 4, cerebrovascular disease: 3,
and others: 3 (esophageal dysmotility: 1, mental
retardation: 1, chronic liver disease: 1). The CAP patients
with comorbid disease were older and had higher PSI
scores than patients without comorbid disease
(P=0.0001 and P=0.0001, respectively), but serum MDA
and TAC concentrations were not significantly different in
these two groups (Table 2).
Pleural effusion (PE) was detected in 18 (27%) CAP
patients on admission. Although not statistically
significant, these patients were older and had higher PSI
539

Oxidative Stress Markers and CRP in CAP Patients

BİRCAN, A et al.

Turk J Med Sci

Table 2. The evaluation of CAP patients according to presence of predisposing factors or pleural effusion.
CAP
Pleural Effusion

n
Gender F/M
Mean age, years
Smokers
Nonsmokers
9
WBC, n × 10 /L
CRP, mg/L
MDA, nmol/L
TAC, mmol Trolox equivalent/L
PSI

Comorbid Disease

(-)

(+)

(-)

(+)

49
8/41
39 ± 23
28
21
17.9 ± 8.3
151.7 ± 64.0
3.333 ± 0.874
1.955 ± 0.697
56.4 ± 38.3

18
3/15
45 ± 24
8
10
15.7 ± 10.7
149.3 ± 63.1
2.821 ± 0.719
1.761 ± 0.597
93.1 ± 53.0

44
4/40
27 ± 15
29
15
16.9 ± 8.5
145.8 ± 62.2
3.197 ± 0.815
1.951 ± 0.678
43.7 ± 28.4

23
7/16
64 ± 17
7
16
17.9 ± 9.9
159.8 ± 65.4
3.192 ± 0.962
1.811 ± 0.669
106.1 ± 42.6

CAP: community-acquired pneumonia; WBC: white blood cell count; CRP: C-reactive protein; MDA: malondialdehyde; TAC: total antioxidant capacity; PSI: pneumonia severity index.

scores and had statistically significantly lower MDA levels
than PE (-) CAP patients (P=0.006 and P=0.030,
respectively). There were no statistical differences in
serum TAC or CRP levels and WBC counts between the
CAP patients with or without PE (Table 2). In PE (+) CAP
patients, the CXR scores were found to be higher than in
PE (-) patients (P=0.0001).
According to findings on CXR, CAP patients were
grouped as having unilobar or multilobar involvement in
51 (86%) and 16 (24%) patients, respectively. However,
there were no statistically significant differences between
the lobar and multilobar involvement in terms of serum
MDA, TAC and CRP levels or WBC counts (Table 3). We
also evaluated the patient’s CXR according to Majewska et
al. (21), and no association was found among the
parameters studied with the radiological scores.

According to the calculated PSI scores, our patients
were grouped as follows: group I: 31 patients, group II:
5 patients, group III: 9 patients, group IV: 16 patients,
and group V: 6 patients. Only one of the patients in group
V died due to complication of the insertion of a chest
tube. We could not find any significant differences among
these groups in terms of mean levels of MDA, TAC, CRP
and WBC counts. Although the CXR scores were also not
different among these groups (P=0.054), they showed
good correlation with PSI scores (r=0.420, P=0.0001).
The CAP patients were also grouped as low risk (PSI I-III)
and high risk (PSI IV-V) and the results of the parameters
studied in these groups are shown in Table 4.
The etiological agent was identified in 21 patients
(30%) based on cultures from sputum, blood, and pleural
fluid. The most frequently isolated microorganisms were

Table 3. The relation between pneumonic infiltration on chest X-ray with the laboratory variables.

Age, years
9
WBC, n × 10 /L
CRP, mg/L
MDA, nmol/L
TAC, mmol Trolox equivalent/L

Unilobar involvement
n=51

Multilobar involvement
n=16

P

40 ± 23
17.9 ± 9.2
153.1 ± 64.2
3.212 ± 0.862
1.938 ± 0.688

41 ± 25
15.6 ± 8.1
144.5 ± 61.8
3.142 ± 0.881
1.791 ± 0.630

ns
ns
ns
ns
ns

WBC: white blood cell count; CRP: C-reactive protein; MDA: malondialdehyde; TAC: total antioxidant capacity; ns: not
significant.
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Table 4. Comparison of the two groups of CAP patients with low- or high-risk according to Fine’s scale.

PSI
CXR score
9
WBC, n × 10 /L
CRP, mg/L
MDA, nmol/L
TAC, mmol Trolox equivalent/L

Low-risk group
≤ 90 points
n=45
41.4 ± 24.9
2.36 ± 1.23
17.7 ± 9.2
138.7 ± 63.9
3.164 ± 0.842
1.930 ± 0.682

High-risk group
> 90 points
n=22
120.0 ± 30.5
3.19 ± 1.17
15.9 ± 8.2
177.1 ± 56.4
3.243 ± 0.936
1.858 ± 0.682

P
0.0001
0.010
ns
0.005
ns
ns

PSI: pneumonia severity index; CXR: chest X-ray; WBC: white blood cell count; CRP: C-reactive protein; MDA: malondialdehyde; TAC: total antioxidant capacity; ns: not significant.

Streptococcus pneumoniae (13 cases); the others
included gram-negative microorganisms (Klebsiella
pneumoniae, 5 cases; Pseudomonas aeruginosa, 1 case)
and Staphylococcus aureus (2 cases). Multiple pathogenic
bacteria were isolated in only two patients. There was no
statistically significant difference in MDA and TAC
concentrations measured in patients with or without a
positive microbiologic result.

Discussion
The respiratory tract has a great external surface area
that directly interfaces with the external environment and
exposes it to inhaled noxious antigens and particles
including etiologic agents of pneumonia. This makes it a
vulnerable target for oxidative injury. TBARS (mostly
MDA) and free radicals have been reported to be
increased in inflammatory lung diseases including
pneumonia (20). In the present study, we found
statistically significantly high MDA levels and low TAC
levels in the serum of CAP patients compared to those in
control subjects, indicating increased oxidative stress in
the blood of patients with pneumonia. Our results are
supported by the studies reported previously (9,1823,26,27). The occurrence of oxidant/antioxidant
imbalance through decreased serum total antioxidant
status (TAS) in patients with pneumonia was concluded in
the preliminary results of the study by Katsoulis et al. (9).
Increased oxidative stress and decreased enzymic and
non-enzymic antioxidant activities in children with acute
pneumonia were also concluded in the study by Cemek et
al. (18). Similarly, Duflo et al. (20) studied alveolar and
serum oxidative stress in ventilator-associated pneumonia
(VAP) and found that plasma and alveolar TBARS

increased significantly in patients who developed VAP
compared with those who did not, by 43% and 259%,
respectively. In the study by Majewska et al. (21), the
occurrence of oxidative stress in the respiratory tract
related to lower airways infection was proven by the
demonstration of elevated H2O2 and TBARS exhalation.
Compatible with the aforementioned studies, Nowak et
al. (22) stated that an enhanced process of lipid
peroxidation occurs during bacterial pneumonia and
increased levels of circulating markers of lipid peroxides
return to normal values quicker than the concentration of
MDA during recovery. In an another study by Li et al.
(23), the serum levels of superoxide dismutase (SOD),
glutathione peroxidase (GSH-Px) and MDA were all
significantly higher, while TAC was significantly lower in
68 patients with pneumonia, and it was concluded that
determination of serum SOD, GSH-Px, TAC and MDA
might be helpful for the diagnosis and treatment of
pneumonia. In the current study, in contrast to the
previous ones, the serum TAC level was measured instead
of specific components of the antioxidant defense system
with an assay suitable for serum samples (24). Most of
the antioxidants that take part in this colorimetric method
are extracellularly located, although there is evidence that
major intracellular antioxidant enzymes such as SOD and
GSH-Px are also detectable extracellularly even in smaller
amounts.
In contrast to Katsoulis et al. (9), the current study
showed a mildly positive correlation between serum TAC
level and smoking status, and an increased TAC level on
admission if smoking coexisted. This finding is in
accordance with the previous study by Abou-Seif (29),
which stated that erythrocyte SOD and catalase as well as
plasma SOD activities were elevated in smokers compared
541
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with the control group. Stolarek et al. (28) studied the
differential effect of cigarette smoking on H2O2 and
TBARS exhaled in patients with CAP, and demonstrated a
decreased level of exhaled H2O2 and increased
concentration of exhaled TBARS within up to five days
after the diagnosis of CAP and initiation of antibiotic
therapy. The attenuated exhalation of H2O2 level in EBC
may indicate the enhanced decomposition of H2O2,
impaired inflammatory response to bacterial infection or
the attenuation of phagocyte oxidative response early in
the course of infection, whereas increased TBARs seems
to be associated with a delayed effect of increased
oxidative stress. Pre-existing chronic bronchitis enhances
lung antioxidant defense, thus additional oxidant burden
related with pneumonia did not result in further rise in
H2O2 exhalation (28).
Similar results were found in the study by Katsoulis et
al. (9), with respect to oxidative stress levels in patients
with comorbid disease. In this group, the MDA or TAC
levels were not different than in the group without
comorbid disease (Table 3). Pneumonic CXR score is a
simple and inexpensive measure to evaluate the extent of
pneumonic infiltration in the lung, but it should be noted
that size and severity of inflammatory alveolar infiltrate
have some limitations that may affect analyzed
correlations. In the present study, there was no
correlation between pneumonic CXR score and serum
MDA or TAC levels. There are discordant results in the
literature about the relationship between the radiological
extension and oxidant/antioxidant balance in pneumonia
patients. In the study by Katsoulis et al. (9), no significant
difference was reported in TAS levels on the day of
admission according to the CXR findings, complications or
distribution of the pneumonic infiltration. However, the
TAS difference (ΔTAS, between admission and the 7th
day) was found to be different in the radiologic
distribution groups, as lobar vs non-lobar. In another
study by Majewska et al. (21), weak or moderate
correlations between exhaled markers of systemic
inflammatory response and pneumonic CXR score were
detected. In this study, it was also suggested that EBC
H2O2 and TBARS had a limited predictive value for
monitoring with respect to size and severity of
pneumonic infiltrate. Thus, we can speculate that some
correlation between the radiological scores and
laboratory variables might be detected if we had used
thorax computed tomography (CT) images to evaluate
the spatial distribution of the infiltration.
542
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In the current study, a positive bacterial culture result
was achieved in 30% of patients (21 cases), and
Streptococcus pneumoniae was the most frequently
isolated microorganism (in 13 cases). However, no
statistically significant differences in MDA and TAC
concentrations were obtained in the patients with or
without a positive microbiologic result. These results
were supported by the study of Laskaj et al. (19), who
studied gamma-glutamyltransferase activity and TAS in
serum and platelets of 60 CAP patients. They confirmed
bacterial pneumonia in 53.3% (32/60), atypical
pneumonia in 38.3% (23/60) and interstitial pneumonia
in 8.3% (5/60) of the study patients, and reported no
statistically significant difference in the study parameters
according to the etiology of pneumonia. In this regard,
Katsoulis et al. (9) reported an increased TAS change in
patients with gram-negative pneumonia, although no
significant difference had been found in TAS on admission
between the groups of pneumonia due to gram-positive
or gram-negative agents.
It is well known that inflammatory cells such as
neutrophils, lymphocytes and macrophages can play a
significant role in releasing ROS during the phagocytotic
process. Although TAC levels negatively correlated with
WBC counts (r= -0.646, P=0.0001) in the whole study
population, there was no such correlation among the
WBC and TAC or MDA levels when the population was
restricted to CAP patients. This result was similar with
the previous studies (9,22). A negative correlation was
found between the TAS change and total WBC, and it was
suggested that other sources of ROS may be involved in
peripheral oxidant/antioxidant imbalance in CAP patients
(9). In the present study, it is of interest to note that CRP
concentration was not correlated with serum MDA or
TAC levels in the CAP patients, although it was negatively
correlated with TAC in the whole study population. CRP
concentration is a very useful nonspecific biochemical
marker of inflammation, and its measurement in CAP
patients contributes to diagnosis and assessment of the
severity of the disease. The lack of relationship between
CRP levels and TAC may be attributed to the presence of
a high serum CRP level in all CAP patients and to the fact
that TAC represents a marker of global defense against
free radicals. To our knowledge, there is no other study
in the literature evaluating serum CRP levels and
oxidant/antioxidant status assessed by MDA and TAC
levels in patients with CAP. Nevertheless, a supportive
finding of our results was reported in a recent study done
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in hemodialyzed patients by Samouilidou et al. (30). In
that study, a significant positive correlation between
logCRP and reactive oxygen metabolites (d-ROMs) and no
association between the concentrations of TAC and MDA
with CRP was observed (30).
Making essential treatment decisions such as
hospitalization and choice of antimicrobial treatment in
CAP patients should be based on pneumonia severity
assessment. Different scoring systems have been
developed for a more objective assessment of CAP
severity. In our study, most of the patients (31/67) were
classified as group I according to Fine et al. (12). As
shown in Table 3, serum TAC and MDA levels on
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admission were not different in low-risk or high-risk
groups of CAP patients. In the study by Katsoulis et al.
(9), although no correlation was found between TAS1,
TAS2 and ΔTAS and disease severity, it was concluded
that change in TAS seems to be influenced by disease
severity.
In conclusion, our findings indicate that single
measurement of serum TAC or MDA in CAP patients on
admission day may predict the oxidative damage through
decreased serum TAC and increased lipid peroxidation,
but this oxidative stress does not seem to predict the
severity of disease, as was shown with the CRP
measurement.
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